Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 T618I-Mutated Colony Stimulating Factor 3 Receptor in Chronic Neutrophilic Leukemia and Chronic Myelomonocytic Leukemia Patients who Underwent Allogeneic Stem Cell Transplantation.

Literature DB >> 25932451

T618I-Mutated Colony Stimulating Factor 3 Receptor in Chronic Neutrophilic Leukemia and Chronic Myelomonocytic Leukemia Patients who Underwent Allogeneic Stem Cell Transplantation.

Sung-Eun Lee¹, Irene Jo², Woori Jang², Yonggoo Kim², Kyungja Han², Myungshin Kim².

Abstract

Entities: Chemical Disease Gene Mutation Species

Mesh：

Substances：

Year: 2015 PMID： 25932451 PMCID： PMC4390711 DOI： 10.3343/alm.2015.35.3.376

Source DB: PubMed Journal: Ann Lab Med ISSN： 2234-3806 Impact factor: 3.464

× No keyword cloud information.

10 in total

Review 1. Chronic neutrophilic leukaemia: a distinct clinical entity?

Authors: John T Reilly
Journal: Br J Haematol Date: 2002-01 Impact factor: 6.998

2. WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature.

Authors: M A Elliott; C A Hanson; G W Dewald; S A Smoley; T L Lasho; A Tefferi
Journal: Leukemia Date: 2005-02 Impact factor: 11.528

3. Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia.

Authors: O Kosmider; R Itzykson; V Chesnais; T Lasho; R Laborde; R Knudson; A Gauthier; J Merlevede; L Ades; M Morabito; M Fontenay; A Tefferi; N Droin; E Solary
Journal: Leukemia Date: 2013-06-18 Impact factor: 11.528

4. The CSF3R T618I mutation as a disease-specific marker of atypical CML post allo-SCT.

Authors: S E Langabeer; S L McCarron; K Haslam; M T O'Donovan; E Conneally
Journal: Bone Marrow Transplant Date: 2014-03-10 Impact factor: 5.483

5. Identification of risk factors in atypical chronic myeloid leukemia.

Authors: Massimo Breccia; Francesca Biondo; Roberto Latagliata; Ida Carmosino; Franco Mandelli; Giuliana Alimena
Journal: Haematologica Date: 2006-10-17 Impact factor: 9.941

Review 6. An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms.

Authors: A Tefferi; J Thiele; A M Vannucchi; T Barbui
Journal: Leukemia Date: 2014-01-20 Impact factor: 11.528

7. Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia.

Authors: J M Hernández; M C del Cañizo; A Cuneo; J L García; N C Gutiérrez; M González; G Castoldi; J F San Miguel
Journal: Ann Oncol Date: 2000-04 Impact factor: 32.976

8. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.

Authors: A Pardanani; T L Lasho; R R Laborde; M Elliott; C A Hanson; R A Knudson; R P Ketterling; J E Maxson; J W Tyner; A Tefferi
Journal: Leukemia Date: 2013-04-22 Impact factor: 11.528

Review 9. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.

Authors: Jason Gotlib; Julia E Maxson; Tracy I George; Jeffrey W Tyner
Journal: Blood Date: 2013-07-29 Impact factor: 22.113

10. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.

Authors: Julia E Maxson; Jason Gotlib; Daniel A Pollyea; Angela G Fleischman; Anupriya Agarwal; Christopher A Eide; Daniel Bottomly; Beth Wilmot; Shannon K McWeeney; Cristina E Tognon; J Blake Pond; Robert H Collins; Basem Goueli; Stephen T Oh; Michael W Deininger; Bill H Chang; Marc M Loriaux; Brian J Druker; Jeffrey W Tyner
Journal: N Engl J Med Date: 2013-05-09 Impact factor: 91.245